Genmab receives patent for HuMax-HepC
07-Nov-2005
"The issuance of the HuMax-HepC patent marks another important milestone in building our business," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "The patent provides broad protection over this unique antibody and gives us a potential edge over other biotech companies competing in the same arena."
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.